We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHM icon
351
Pultegroup
PHM
$24.6B
$46.3M 0.04%
420,214
-41,619
-9% -$4.73M
SBAC icon
352
SBA Communications
SBAC
$19B
$46.2M 0.04%
235,187
-4,205
-2% -$832K
TER icon
353
Teradyne
TER
$63.1B
$46M 0.04%
309,933
+8,849
+3% +$1.12M
CHD icon
354
Church & Dwight Co
CHD
$23.7B
$45.8M 0.04%
441,795
-53,697
-11% -$5.68M
BMRN icon
355
BioMarin Pharmaceuticals
BMRN
$11.6B
$45.4M 0.04%
551,553
+303,207
+122% +$25.2M
STE icon
356
Steris
STE
$22.7B
$45.2M 0.04%
205,847
-3,082
-1% -$670K
TPL icon
357
Texas Pacific Land
TPL
$28B
$45.2M 0.04%
184,596
+105,252
+133% +$22.1M
ZBH icon
358
Zimmer Biomet
ZBH
$18.5B
$45.1M 0.04%
415,779
-15,363
-4% -$1.81M
IBKR icon
359
Interactive Brokers
IBKR
$39.5B
$44.7M 0.04%
1,458,540
+291,844
+25% +$8.71M
NBIX icon
360
Neurocrine Biosciences
NBIX
$16.9B
$44.6M 0.04%
324,288
+2,181
+0.7% +$299K
DASH icon
361
DoorDash
DASH
$87.4B
$44.6M 0.04%
409,866
+13,639
+3% +$1.64M
FERG icon
362
Ferguson
FERG
$48.5B
$44.5M 0.04%
229,924
-3,992
-2% -$837K
AXON
363
Axon Enterprise
AXON
$48.9B
$44.3M 0.04%
150,700
+2,292
+2% +$684K
EQH icon
364
Equitable Holdings
EQH
$13.1B
$44.2M 0.04%
1,080,609
+67,176
+7% +$2.63M
IFF icon
365
International Flavors & Fragrances
IFF
$20.6B
$44.1M 0.04%
463,364
-8,500
-2% -$779K
XYZ
366
Block Inc
XYZ
$48.9B
$43.4M 0.04%
673,246
-1,048
-0.2% -$73.3K
EXPD icon
367
Expeditors International
EXPD
$22.3B
$43.3M 0.04%
346,815
-44,898
-11% -$5.35M
SRPT icon
368
Sarepta Therapeutics
SRPT
$1.73B
$42.8M 0.04%
270,941
+160,942
+146% +$20.7M
ALNY icon
369
Alnylam Pharmaceuticals
ALNY
$29.5B
$42.1M 0.04%
173,327
-362
-0.2% -$57.2K
INVH icon
370
Invitation Homes
INVH
$18.1B
$42.1M 0.04%
1,171,761
+4,484
+0.4% +$156K
GGG icon
371
Graco
GGG
$13B
$42M 0.04%
529,668
-32,239
-6% -$2.7M
PTC icon
372
PTC
PTC
$15.2B
$41.9M 0.04%
230,673
+5,906
+3% +$1.06M
VRT icon
373
Vertiv
VRT
$104B
$41.7M 0.04%
481,494
+74,421
+18% +$6.78M
UTHR icon
374
United Therapeutics
UTHR
$22B
$41.7M 0.04%
130,842
-6,901
-5% -$1.83M
ES icon
375
Eversource Energy
ES
$27.1B
$41.3M 0.04%
728,318
-2,268
-0.3% -$134K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.